放射線腫瘍学の世界市場レポート 2025年

放射線腫瘍学市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は9.3％で、125億1,000万米ドルに成長します。予測期間中の成長は、精密治療への需要の高まり、外来がんセンターの拡大、治療計画ソフトウェアの採用拡大、がん治療における政府のイニシアチブの高まり、ヘルスケアインフラの拡大などの要因によるものと考えられます。この期間の主な動向には、個別化治療計画、高精細画像、AI搭載画像、定位体放射線治療（SBRT）の進歩、ブラキセラピーの進歩などがあります。

がん患者の増加は、今後数年間の放射線腫瘍学市場の成長を牽引すると予想されます。がんは、体内の異常細胞の制御不能な増殖と拡散を特徴とし、患者数が増加しています。この増加は主に、がんの開発リスクを著しく高める不健康なライフスタイルの普及によるものです。放射線腫瘍学は、高エネルギーの放射線を利用してがん細胞を破壊し、腫瘍を縮小させ、症状を緩和し、手術や化学療法の効果を高めることにより、がんの治療に貢献しています。高度な放射線技術は、精度と治療成績をさらに向上させています。例えば、2024年10月、英国の政府機関である国民保健サービス（NHS）は、2022年に新たにがんと診断された患者数は34万6,217人で、1日平均948人であったと報告しました。これは2021年の32万9,664件から5％の増加です。その結果、がん患者数の増加が放射線腫瘍学市場の成長に寄与しています。

放射線腫瘍学市場の主要企業は、さまざまながん治療において、治療精度の向上、副作用の最小化、患者の転帰の改善を実現するため、AIを活用した画像処理技術や適応技術を組み込んだ先進的な放射線治療システムの開発に注力しています。AIを活用した放射線治療は、治療計画、画像診断、照射、モニタリングなど、放射線治療の側面を強化するために人工知能技術を活用します。例えば、スウェーデンに本社を置く医療技術企業エレクタは、2024年5月、放射線治療技術を洗練させるために設計された高精細AIエンハンスド・イメージングを特徴とする最新のCT-LinacであるEvoを発表しました。この多用途なシステムは、オフラインおよびオンライン適応放射線治療と高度な画像誘導放射線治療の両方をサポートし、臨床医が個々の患者に合わせて治療をカスタマイズする際に、より高い精度と柔軟性を提供します。この技術革新は、治療の精度と適応性を最適化することにより、患者の予後を改善することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界放射線腫瘍学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の放射線腫瘍学市場：成長率分析
• 世界の放射線腫瘍学市場の実績：規模と成長, 2019-2024
• 世界の放射線腫瘍学市場の予測：規模と成長, 2024-2029, 2034F
• 世界放射線腫瘍学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の放射線腫瘍学市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外部放射線療法
• 内部照射療法
• 世界の放射線腫瘍学市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前立腺がん
• 乳がん
• 肺がん
• 頭頸部がん
• 大腸がん
• 子宮頸がん
• 婦人科がん
• その他の用途
• 世界の放射線腫瘍学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• がん調査機関
• その他のエンドユーザー
• 世界の放射線腫瘍学市場内部照射放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 近接放射線療法
• 腔内密封小線源治療
• 組織内小線源治療
• 腔内近接放射線治療
• 世界の放射線腫瘍学市場外部放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 3Dコンフォーマル放射線治療（3DCRT）
• 強度変調放射線治療（IMRT）
• 定位放射線手術（SRS）
• 定位放射線治療（SBRT）
• 画像誘導放射線治療（IGRT）

第7章 地域別・国別分析

• 世界の放射線腫瘍学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の放射線腫瘍学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 放射線腫瘍学市場：競合情勢
• 放射線腫瘍学市場：企業プロファイル
  • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Varian Medical Systems Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Shimadzu Corporation
• Elekta AB
• Mirion Technologies
• Ion Beam Applications（IBA）
• Accuray Incorporated
• Canon Medical Systems
• Eckert & Ziegler BEBIG
• ViewRay Inc.
• MDS Nordion
• Mevion Medical Systems
• PTW-Freiburg
• Toshiba Medical Systems
• CivaTech Oncology
• ProTom International
• Radcal Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 放射線腫瘍学市場2029：新たな機会を提供する国
• 放射線腫瘍学市場2029：新たな機会を提供するセグメント
• 放射線腫瘍学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Radiation oncology is a specialized field of medicine that uses high-energy radiation to treat cancer by damaging the deoxyribonucleic acid (DNA) of malignant cells, thereby inhibiting their growth and spread. This approach employs advanced techniques to deliver precise treatment, focusing on targeting the affected area while minimizing damage to surrounding healthy tissues.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary types of radiation oncology include external beam radiation therapy and internal beam radiation therapy. Internal beam radiation therapy, also known as brachytherapy, involves placing radioactive material directly into or near a tumor to deliver concentrated, localized radiation. It is used in the treatment of various cancers, including prostate, breast, lung, head and neck, colorectal, cervical, gynecological cancers, and others. Key end users of this treatment include hospitals, cancer research institutes, and other healthcare facilities.

The radiation oncology market research report is one of a series of new reports from The Business Research Company that provides radiation oncology market statistics, including radiation oncology industry global market size, regional shares, competitors with a radiation oncology market share, detailed radiation oncology market segments, market trends and opportunities, and any further data you may need to thrive in the radiation oncology industry. This radiation oncology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The radiation oncology market size has grown strongly in recent years. It will grow from$7.99 billion in 2024 to $8.75 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to factors such as the rising incidence of cancer, increased healthcare spending, growth in healthcare infrastructure investments, an aging population, and a higher prevalence of complex cancer cases.

The radiation oncology market size is expected to see strong growth in the next few years. It will grow to$12.51 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth during the forecast period can be attributed to factors such as the growing demand for precision treatments, the expansion of outpatient cancer centers, increased adoption of treatment planning software, rising government initiatives in cancer care, and expanding healthcare infrastructure. Key trends during this period include personalized treatment plans, high-definition imaging, AI-powered imaging, advancements in stereotactic body radiation therapy (SBRT), and progress in brachytherapy.

The increasing number of cancer cases is expected to drive the growth of the radiation oncology market in the coming years. Cancer, characterized by the uncontrolled growth and spread of abnormal cells in the body, affects a growing number of patients. This rise is primarily due to the widespread adoption of unhealthy lifestyles that significantly heighten the risk of developing cancer. Radiation oncology helps treat cancer by utilizing high-energy radiation to destroy cancer cells, shrink tumors, alleviate symptoms, and enhance the effectiveness of surgery and chemotherapy. Advanced radiation techniques have further improved precision and outcomes. For example, in October 2024, the National Health Service (NHS), a UK-based government body, reported that there were 346,217 new cancer diagnoses in 2022, averaging 948 per day. This marked a 5% increase from the 329,664 diagnoses in 2021. As a result, the rising number of cancer cases is contributing to the growth of the radiation oncology market.

Leading companies in the radiation oncology market are focusing on developing advanced radiation therapy systems that incorporate AI-powered imaging and adaptive technologies to improve treatment precision, minimize side effects, and enhance patient outcomes for various cancer treatments. AI-powered radiotherapy leverages artificial intelligence technologies to enhance aspects of radiation therapy, including treatment planning, imaging, delivery, and monitoring. For example, in May 2024, Elekta, a Sweden-based medical technology company, introduced Evo, its latest CT-Linac, which features high-definition AI-enhanced imaging designed to refine radiation therapy techniques. This versatile system supports both offline and online adaptive radiation therapy as well as advanced image-guided radiation therapy, offering clinicians greater precision and flexibility in customizing treatments for individual patients. The innovation aims to improve patient outcomes by optimizing the accuracy and adaptability of treatments.

In June 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Fusion Pharmaceuticals for an undisclosed sum. With this acquisition, AstraZeneca seeks to strengthen its oncology portfolio by incorporating Fusion's innovative radioconjugate (RC) technology, particularly for enhancing targeted cancer therapies such as FPI-2265 for metastatic castration-resistant prostate cancer (mCRPC). The goal is to advance precision oncology and reduce dependence on traditional treatments. Fusion Pharmaceuticals, a clinical-stage oncology company based in Canada, focuses on developing next-generation radiopharmaceuticals as precision medicines.

Major players in the radiation oncology market are Hitachi Ltd., Siemens Healthineers, Philips Healthcare, GE Healthcare Technologies Inc., Varian Medical Systems, Shimadzu Corporation, Elekta AB, Mirion Technologies, Ion Beam Applications (IBA), Accuray Incorporated, Canon Medical Systems, Eckert & Ziegler BEBIG, ViewRay Inc., MDS Nordion, Mevion Medical Systems, PTW-Freiburg, Toshiba Medical Systems, CivaTech Oncology, ProTom International, Radcal Corporation, and ScandiDos.

North America was the largest region in the radiation oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiation oncology report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiation oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiation oncology market consists of revenues earned by entities by providing services such as tumor board consultations, radiation oncology equipment maintenance, telemedicine consultations, stereotactic radiosurgery (SRS), and image-guided radiation therapy (IGRT). The market value includes the value of related goods sold by the service provider or included within the service offering. The radiation oncology market also includes sales of radiation therapy equipment, treatment planning software, dosimetry systems, radiation protection products, and medical consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiation Oncology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiation oncology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiation oncology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiation oncology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy
• 2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Cervical Cancer; Gynecological Cancer; Other Applications
• 3) By End-User: Hospitals; Cancer Research Institutes; Other End-Users
• Subsegments:

1) By Internal Beam Radiation Therapy; Brachytherapy; Endocavitary Brachytherapy; Interstitial Brachytherapy; Intraluminal Brachytherapy

2) By External Beam Radiation Therapy; 3D Conformal Radiation Therapy (3DCRT); Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Radiosurgery (SRS); Stereotactic Body Radiation Therapy (SBRT); Image-Guided Radiation Therapy (IGRT)

• Companies Mentioned: Hitachi Ltd.; Siemens Healthineers; Philips Healthcare; GE Healthcare Technologies Inc.; Varian Medical Systems
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiation Oncology Market Characteristics

3. Radiation Oncology Market Trends And Strategies

4. Radiation Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Radiation Oncology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiation Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiation Oncology Market Growth Rate Analysis
• 5.4. Global Radiation Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiation Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiation Oncology Total Addressable Market (TAM)

6. Radiation Oncology Market Segmentation

• 6.1. Global Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• 6.2. Global Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head And Neck Cancer
• Colorectal Cancer
• Cervical Cancer
• Gynecological Cancer
• Other Applications
• 6.3. Global Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Cancer Research Institutes
• Other End-Users
• 6.4. Global Radiation Oncology Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brachytherapy
• Endocavitary Brachytherapy
• Interstitial Brachytherapy
• Intraluminal Brachytherapy
• 6.5. Global Radiation Oncology Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3D Conformal Radiation Therapy (3DCRT)
• Intensity-Modulated Radiation Therapy (IMRT)
• Stereotactic Radiosurgery (SRS)
• Stereotactic Body Radiation Therapy (SBRT)
• Image-Guided Radiation Therapy (IGRT)

7. Radiation Oncology Market Regional And Country Analysis

• 7.1. Global Radiation Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiation Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiation Oncology Market

• 8.1. Asia-Pacific Radiation Oncology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiation Oncology Market

• 9.1. China Radiation Oncology Market Overview
• 9.2. China Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiation Oncology Market

• 10.1. India Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiation Oncology Market

• 11.1. Japan Radiation Oncology Market Overview
• 11.2. Japan Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiation Oncology Market

• 12.1. Australia Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiation Oncology Market

• 13.1. Indonesia Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiation Oncology Market

• 14.1. South Korea Radiation Oncology Market Overview
• 14.2. South Korea Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiation Oncology Market

• 15.1. Western Europe Radiation Oncology Market Overview
• 15.2. Western Europe Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiation Oncology Market

• 16.1. UK Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiation Oncology Market

• 17.1. Germany Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiation Oncology Market

• 18.1. France Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiation Oncology Market

• 19.1. Italy Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiation Oncology Market

• 20.1. Spain Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiation Oncology Market

• 21.1. Eastern Europe Radiation Oncology Market Overview
• 21.2. Eastern Europe Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiation Oncology Market

• 22.1. Russia Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiation Oncology Market

• 23.1. North America Radiation Oncology Market Overview
• 23.2. North America Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiation Oncology Market

• 24.1. USA Radiation Oncology Market Overview
• 24.2. USA Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiation Oncology Market

• 25.1. Canada Radiation Oncology Market Overview
• 25.2. Canada Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiation Oncology Market

• 26.1. South America Radiation Oncology Market Overview
• 26.2. South America Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiation Oncology Market

• 27.1. Brazil Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiation Oncology Market

• 28.1. Middle East Radiation Oncology Market Overview
• 28.2. Middle East Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiation Oncology Market

• 29.1. Africa Radiation Oncology Market Overview
• 29.2. Africa Radiation Oncology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiation Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiation Oncology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiation Oncology Market Competitive Landscape And Company Profiles

• 30.1. Radiation Oncology Market Competitive Landscape
• 30.2. Radiation Oncology Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Varian Medical Systems Overview, Products and Services, Strategy and Financial Analysis

31. Radiation Oncology Market Other Major And Innovative Companies

• 31.1. Shimadzu Corporation
• 31.2. Elekta AB
• 31.3. Mirion Technologies
• 31.4. Ion Beam Applications (IBA)
• 31.5. Accuray Incorporated
• 31.6. Canon Medical Systems
• 31.7. Eckert & Ziegler BEBIG
• 31.8. ViewRay Inc.
• 31.9. MDS Nordion
• 31.10. Mevion Medical Systems
• 31.11. PTW-Freiburg
• 31.12. Toshiba Medical Systems
• 31.13. CivaTech Oncology
• 31.14. ProTom International
• 31.15. Radcal Corporation

32. Global Radiation Oncology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiation Oncology Market

34. Recent Developments In The Radiation Oncology Market

35. Radiation Oncology Market High Potential Countries, Segments and Strategies

• 35.1 Radiation Oncology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiation Oncology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiation Oncology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34946_Radiation_Oncology_GMR_2025